HCAT Earnings & Financial Statements
Health Catalyst, Inc.
$1.80
+$0.06(+3.45%)
38
Overall
40
Value
20
Tech
55
Quality
Market Cap
$130.95M
Volume
306.82K
52W Range
$0.96 - $3.62
Target Price
$1.77
HCAT earnings and financial statements: Health Catalyst, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
HCAT Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $311.14M | $306.58M | $295.94M | $276.24M | $241.93M |
| Cost of revenue | $159.46M | $165.81M | $164.10M | $143.05M | $124.35M |
| Operating income | -$160.85M | -$69.81M | -$126.90M | -$140.00M | -$143.65M |
| EBITDA | -$106.63M | -$25.12M | -$83.16M | -$84.65M | -$106.12M |
| Net income | -$177.97M | -$69.50M | -$118.15M | -$137.40M | -$153.21M |
| EPS (diluted) | $-2.55 | $-1.15 | $-2.09 | $-2.63 | $-3.23 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $502.64M | $858.93M | $701.81M | $752.29M | $832.10M |
| Total liabilities | $256.86M | $493.72M | $334.89M | $327.28M | $310.00M |
| Shareholders’ equity | $245.78M | $365.21M | $366.92M | $425.01M | $522.10M |
| Cash and equivalents | $50.81M | $249.65M | $106.28M | $116.31M | $193.23M |
| Long-term debt | $165.83M | $167.47M | $245.71M | $244.54M | $201.19M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $731.0K | $14.56M | -$33.08M | -$35.27M | -$23.12M |
| Capital expenditure | -$1.73M | -$2.11M | -$14.31M | -$17.41M | -$18.47M |
| Free cash flow | -$1.04M | $12.44M | -$35.43M | -$52.68M | -$41.59M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HCAT | $1.80 | +3.4% | 306.82K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |